I

Immuron Limited
D

IMRN

1.98000
USD
0.06
(3.13%)
Market Closed
Volume
401
EPS
0
Div Yield
0
P/E
-4
Market Cap
11,285,919
OverviewSignalsIdeasNews
Related Instruments
    A
    AMRN
    -0.06090
    (-8.93%)
    0.62120 USD
    I
    IMGN
    0
    (0%)
    0.000000 USD
    I
    INO
    -0.670
    (-6.28%)
    10.000 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    M
    MRNS
    0.00000
    (0.00%)
    1.40000 USD
    N
    NVAX
    -0.250
    (-1.95%)
    12.560 USD
    More
News

Title: Immuron Limited

Sector: Healthcare
Industry: Biotechnology
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.